期刊文献+

慢性阻塞性肺疾病患者呼出气冷凝液中白介素9水平变化分析 被引量:6

Analysis of Interleukin- 9 in Exhaled Breath Condensate of COPD Patients
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)患者及正常吸烟者呼出气冷凝液(EBC)中白介素9(IL-9)水平的变化。方法选取2006年9—12月北京大学第一医院诊治的COPD稳定期患者20例,COPD急性加重期患者9例,健康非吸烟人群14例,健康吸烟者10例。收集EBC前使用Jaeger肺功能仪测定吸入支气管扩张剂后第1秒用力呼气末容积占预计值的百分比(FEV1%)和第1秒用力呼气末容积/用力肺活量(FEV1/FVC),采用双抗夹心酶联免疫吸附法检测各组EBC中IL-9水平。应用SPSS统计学软件进行数据分析。结果 4组FEV1%、FEV1/FVC比较,差异均有统计学意义(P<0.05);其中健康吸烟组、COPD稳定期组、COPD急性加重期组FEV1%较健康非吸烟组降低,COPD稳定期组、COPD急性加重期组较健康吸烟组降低,COPD急性加重期组较COPD稳定期组降低(P<0.05);COPD稳定期组、COPD急性加重期组FEV1/FVC较健康非吸烟组和健康吸烟组降低,COPD急性加重期组较COPD稳定期组降低(P<0.05)。4组EBC中IL-9水平比较,差异无统计学意义(P>0.05)。COPD稳定期及急性加重期患者EBC中IL-9水平与年龄、累计吸烟量、FEV1%、FEV1/FVC均无直线相关关系(P>0.05)。结论未能发现不同组间EBC中IL-9水平的差异及与吸烟及COPD患者气道炎性反应间的关系。EBC中IL-9水平在COPD气道炎症中的作用有待进一步研究。 Objective To investigate the concentration of IL-9 in exhaled breath condensate( EBC) in COPD patients and smokers without COPD. Methods 20 stable COPD patients,9 acute COPD patients,14 healthy non- smokers and 10 healthy smokers treated in Peking University First Hospital from September to December in 2006 were selected. FEV1% and FEV1/FVC were detected by using Jaeger respiratory function instrument before collecting EBC. ELISA method was used to detect the concentration of IL- 9 of the EBC in each group. SPSS software was used to perform statistical analysis. Results The FEV1%and FEV1/FVC among the four groups showed statistically significant differences( P〈 0. 05). As for the FEV1%,the healthy smokers,stable COPD patients,acute COPD patients were lower than the healthy non- smokers,and the stable COPD patients and acute COPD patients were lower than the healthy smokers,and the acute COPD patients were lower than the stable COPD patients( P〈 0. 05). As for the FEV1/FVC,the stable COPD patients and acute COPD patients were lower than the healthy non- smokers and healthy smokers,and the acute COPD patients were lower than the stable COPD patients( P〈 0. 05). The IL- 9levels of the four groups showed no statistically significant difference( P〉 0. 05). The IL- 9 level of stable COPD patients and acute COPD patients showed no linear correlation with age,cumulative cigarette consumption,FEV1% and FEV1/FVC( P〈 0. 05). Conclusion In this study,the significant difference in IL- 9 concentration in EBC between stable COPD patients,acute COPD patients,healthy smokers and healthy non- smokers don't found. The role of IL- 9 concentration in EBC in COPD need further investigation.
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第33期3932-3937,共6页 Chinese General Practice
关键词 肺疾病 慢性阻塞性 白介素9 吸烟 Pulmonary disease chronic obstructive Interleukin-9 Smoking
  • 相关文献

参考文献14

  • 1Kharitonov SA, Barnes PL Biomarkers of some pulmonary diseases inexhaled breath [ J]: Biomarkers,2002, 7 (1 ) : 1-32.
  • 2Kelleher K, Bean K, Clark SC, et al. Human interleukin -9: ge-nomic sequence, chromosomal lacation, and sequences essential for itsexpression in human T - cell leukemia vims ( HTLV ) - 1 - transfor-maed human T cells [J]: Blood, 1991, 77 (7) : 1436 -1441.
  • 3Doull U, Lawrence S, Watso M, et al. Alletic association of genemarkers on chromosomes 5 q and 11 q with atopy and bronchial hyperre-sponsiveness [ J]: Am J Respir Crit Care Med, 1996, 153 (4 Pt1): 1280 -1284.
  • 4Demolin JB, Renauld JC. Interleukin - 9 and its receptor : an overviewof structure and function [ J]: Int Rev Immunol, 1998 , 16 (3/4):354-364.
  • 5Van Snick J, Croethals A, Renauld JC, et al. Cloning and character-ization of a cDNA for a new mouse T cell growth factor (P40) [ J]: JExp Med, 1989,169 ?1): 363 -368.
  • 6Schmitt E, van Brandwijk R,Van Snick J, et al. TCGF HI/P40 isproduced by native murine CD4 + T cell but is not a general T cell growthfactor [ J]: Eur J Immunol, 1989,19 (11) : 2167 -2170.
  • 7Hunltner L, Druec C, Moeller J, et al. Mast cell growth - enhancingactivity ( MEA) is structurally related and functionally indentical to thenovel mouse T cell growth factor P40/TCGF 瓜[J ] . Eur J Immunol,1990,20 (6) : 1413-1416.
  • 8Hauber HP, Bei^eron C, Tsicopoulos A, et al. Increased expressionof the calcium activated chloride channel in hCLCAl in airways of pa-tients with obstructive chronic bronchitis [ J.] . Can Respir J, 2005 , 12(3) : 143 -146.
  • 9Vermeer PD, Harson R, Einwaiter LA, et al. Interleukin -9 inducesgoblet cell hyperplasia during repair of human airway epithelia [ J ]: AmJ Respir Cell Mol Biol, 2003, 28 (3) : 286-295.
  • 10杨雪梅,万毅新.慢性阻塞性肺疾病大鼠肺内白细胞介素9和γ干扰素的表达[J].中国呼吸与危重监护杂志,2006,5(4):297-300. 被引量:6

二级参考文献27

  • 1刘政,姚婉贞,陈燕,丁艳苓.白细胞介素-9在慢性阻塞性肺病发病中的作用[J].北京大学学报(医学版),2004,36(4):403-406. 被引量:7
  • 2Hunt J.Exhaled breath condensate:an evolving tool for noninvasive evaluation of lung disease.J Allergy Clin Immunol,2002,110:28-34.
  • 3Montuschi P,Barnes PJ.Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci,2002,23:232-237.
  • 4Kharitonov SA,Barnes PL.Exhaled markers of information.Curr Opin Allery Clin Immunol,2001,1:217-224.
  • 5Kharitonov SA,Barnes PL.Biomarkers of some pulmonary diseases in exhaled breath.Biomarkers,2002,7:1-32.
  • 6Montuschi P,Collins JV,Ciabattoni G,et al.Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and heathy smokers.Am J Respir Crit Med,2000,162:1175-1177.
  • 7Gessner C,Kuhn H,Seyfarth HJ,et al.Factors influencing breath condensate volume.Pneumologie,2001,55:414-419.
  • 8van Beurden WJ,Harff GA,Dekhuijzen PN,et al.An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate.Respir Med,2002,96:197-203.
  • 9Panzner P, Lafitte JJ, Tsicopoulos A, et al. Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients with chronic bronchitis with obstruction.Chest,2003; 124:1909 - 1915
  • 10Wang Z, Zheng T, Zhu Z, et al. Interferon-gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med,2000; 192:1587 - 1600

共引文献15

同被引文献85

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部